Dario is right about the courage. He is also, accidentally, right about something far more useful to allocators. The reason Zitron’s clip is on Bloomberg is the same reason it should make you skeptical of your own positioning. By the time a megacap bear thesis is given prime time on the most institutional financial network in the world, the trade is already half-made. The smart money repositioned weeks ago. The retail audience is watching the explanation, not the move.

This is not a column about whether Zitron is right on AI. It is a column about the brutal, repeatable, mechanical reason retail has never had an edge — and why no amount of free information, free brokerage, and free content is ever going to fix it.

The Fear and Greed dial is a retail trap, not a retail tool

CNN’s Fear and Greed Index, the VIX, the AAII bull-bear survey — every public sentiment gauge built in the last forty years has produced the same out-of-sample chart. Retail buys at peak greed. Retail sells at peak fear. The 2020 retail mania bought the top of zero-rate growth. The 2022 retail capitulation sold the bottom of the rate shock. The 2023 AI greed cycle bought NVDA at every 50% rally. The 2024 mid-cycle fear flush sold semis right before the next leg. None of this is in dispute. None of it is hidden. The data is free, the charts are free, the commentary is free.

And it does not matter. The structural disadvantage is not informational. It is procedural. Retail reads the dial as a forecast. Operators read it as inventory. When the dial is at Extreme Greed, retail piles in; operators are distributing. When the dial is at Extreme Fear, retail capitulates; operators are accumulating. The dial does not predict price. It tells you who is on which side of your trade. If you are reading the dial the same way the chyron reads it, you are the inventory.

Ed Zitron on Bloomberg, with 30 weeks of "AI bubble" stories trailing in his wake, is the dial showing greed exhaustion in real time. Allocators who pay attention to this notice it. Allocators who don’t will watch the next CNBC segment for instructions on what to do about it.

Why "more information" will not save retail

The argument that retail has been democratized — that Robinhood, free data, X, and YouTube put the small investor on level ground — is one of the most expensive lies of the last decade. Information was never the bottleneck. Process was. Specifically:

• Primary documents. A retail trader sees the Bloomberg recap. An operator pulls the 10-K, the 6-K, the 8-K, the S-1, the Form D, the warrant indenture. The Bloomberg recap is the operator’s output, three news cycles later, with the live optionality stripped out.
• Deal mechanics. Retail buys "shares." Operators buy specific instruments: common, preferred, prefunded warrants with 4.99% caps, convertible notes with MFN ratchets, secondaries with tag-along rights. Each instrument has a different payoff profile in a drawdown. Retail learns the difference after the drawdown.
• Position sizing. Retail sizes by conviction. Operators size by Kelly fraction, by correlation matrix, by the cost of being wrong. The Zitron-bullish retail trader buys a leveraged SQQQ. The Zitron-bullish operator sells calls into the megacap weighting of their existing book and uses the premium to fund a pre-IPO secondary in something uncorrelated.
• Time horizon. Retail measures performance daily, brags weekly, sells monthly. Operators run vintage-level math on a five-year warrant timeline and don’t care what the dial says on a Tuesday.

None of these gaps close by reading more Bloomberg. They close by changing the workflow. That is the part nobody puts in the YouTube thumbnail.

What "investing alongside operators" actually means

The phrase gets abused, so we want to be precise. It does not mean handing money to someone with a deck. It does not mean copy-trading a Polymarket whale. It does not mean trusting a Substack writer because their tone is confident.

It means one specific thing: being in the same information environment, on the same time horizon, with the same primary-source discipline, as the people who do this work every day. Not as their customer. As their peer. Reading what they read. Arguing with their published positions in public. Updating in writing when the facts change. Building a workflow that compounds — not a tab full of tickers that decays.

That is what the operators on the right side of the Fear and Greed dial have always done. It is what every retail program — Robinhood, the influencer ecosystem, the "we democratized investing" pitch — has explicitly failed to provide. There is no app for this. There is no ETF for this. There is no subscription that hands it to you. There is only the room, and the people who show up to the room daily.

What we publish, and what we won’t pretend to be

This is the lane AdValorem Research sits in. We are not a stock-picking newsletter. We are not selling a signal service. We are not running a course on how to retire by Tuesday. We are a research and education community of 586+ members, and the daily work is the exact set of skills retail systematically lacks: equity warrant enforcement and the Newchip 200-warrant portfolio, pre-IPO secondary structuring, litigation finance, MEV and agentic capital infrastructure, AI/robotics/quantum allocation discipline, and the SPV and syndication mechanics that govern how private capital actually moves.

Two surfaces of that work are public, and worth knowing about as research surfaces — not as offerings:

• market.advalorem.io — the warrant exchange research surface, where we publish the work on accelerator-alumni capital recovery and the Newchip portfolio specifically.
• mev.advalorem.io — the production MEV builder and agentic orderflow research surface, with x402 metric endpoints agents can query and, soon, capital-reservation primitives for autonomous strategies.

Neither is an investment product. Both are education topics. The point of mentioning them is not to pitch you. The point is that the operators publishing in this community use them, and that is the only honest meaning of investing alongside operators in 2026: using the same research surfaces they use, on the same time horizon they use, with the same primary-source discipline they use.

The brutal close

By the time you saw the Zitron clip, the trade was already in motion. The Fear and Greed dial does not reward you for noticing it on Bloomberg. It rewards the operators who positioned for the inflection before Bloomberg’s booker called Zitron’s producer. They did not get on TV. They did not get the retweet. They got the trade.

Retail will continue to oscillate between euphoria and capitulation, buy the top, sell the bottom, and call the cycle "irrational" when it costs them money. That is not a flaw of the system. That is the system. The only way out of the loop is to stop reading sentiment as a forecast and start reading it as inventory — and to build a workflow with the people who already do.

Zitron’s courage on Bloomberg is real. Dario’s amplification is sharp. Both of them are telling you, in different vocabularies, that the chyron has finally caught up to a thesis the smart money has been positioning for since last summer. The question is not whether you agree. The question is whether your portfolio compounds a process — or just collects permission slips from CNBC.

Pick a side of the dial. Then go find the room where the work happens.

For allocators tracking the warrant landscape, this is the kind of detail that rewards close reading. Pre-funded warrants are not novel — they have been around for over a decade — but the way issuers are now combining them with beneficial-ownership ceilings, blocker mechanics, and Section 4(a)(2) private resales is increasingly important to understand. It affects who actually shows up on a 13D, how PIPE economics work, and how warrant inventories settle in distressed and accelerator-adjacent situations.

What a pre-funded warrant actually is

A pre-funded warrant is a warrant whose exercise price has been paid up front — typically at the time of original issuance — leaving a nominal residual exercise price (most commonly $0.0001 per share). Economically, it is nearly identical to common stock. Operationally and legally, it is not common stock until it is exercised, which is the entire point.

Issuers and investors use the structure for three reasons:

• Beneficial-ownership management. A pre-funded warrant typically includes a blocker that prevents the holder from exercising any portion that would push their beneficial ownership above a stated threshold — usually 4.99% or 9.99%. The VCI Global disclosure cites both thresholds, which is standard.
• Avoiding HSR and 13D triggers. Holding warrants below the blocker means the position can be large in dollar terms but small in voting/ownership terms, deferring Hart-Scott-Rodino filings and Section 13(d) reporting until exercise.
• Tax and transfer flexibility. Pre-funded warrants are generally not treated as common stock for several tax purposes, and they can be transferred under private exemptions without triggering certain registration mechanics.

Why the 4.99% / 9.99% cap matters

The cap is not arbitrary. Section 13(d) of the Exchange Act requires beneficial owners of more than 5% of a class of registered equity to file a Schedule 13D (or 13G for passive holders) within ten days of crossing the threshold. The 4.99% blocker is engineered to sit just under that line.

The 9.99% variant maps to a different set of rules — most notably the Investment Company Act of 1940 considerations and the desire to stay below the threshold where an investor might be deemed an affiliate of the issuer. For a fund taking a meaningful position in a small-cap issuer, the cap is the difference between a quiet structured exposure and a public disclosure event.

For an allocator reviewing a PIPE or a warrant-heavy financing in the secondary market, the practical question is usually: how many holders are sitting just under their cap, and what happens when the underlying float thins out? If the issuer does a buyback, a reverse split, or simply has volume contract, beneficial-ownership percentages move even if nobody trades. That can force exercise, force disclosure, or both.

Where this intersects with the SEC's May 2026 reform proposal

On May 19, 2026, the SEC published proposed amendments to the registered offering framework, summarized by Covington & Burling as a meaningful loosening of who qualifies as a Well-Known Seasoned Issuer, what counts as a free writing prospectus, and how state-level blue sky rules apply to listed securities. The 60-day comment window runs into July.

Critically, the proposal extends federal blue sky preemption to securities listed on national exchanges — but unlisted securities, including warrants and convertibles that have not separately been listed, remain subject to state-by-state compliance. The reform is therefore less generous to the warrant ecosystem than the headlines suggest.

The practical consequence for accelerator-warrant and pre-funded-warrant inventories: the underlying common is often listed, but the warrants themselves frequently are not. Settlement, transfer, and exercise paperwork still needs to clear state-level requirements until a registration statement covers them. The reform proposal narrows the gap but does not close it.

Anti-dilution: the other half of the warrant calculus

Most pre-funded warrants and the broader population of investor warrants attach anti-dilution protection — a contractual mechanism that adjusts either the conversion price, the exercise price, or the share count if the issuer later issues equity at a lower price. AngelList's primer walks through the two common formulas: broad-based weighted average and full ratchet.

For warrant holders, anti-dilution is the asymmetric kicker. In a flat-to-up market, the protection is dormant. In a down round — which is exactly when distressed and accelerator warrants become interesting — the protection re-prices the position and can materially shift the cap table. Allocators reviewing a warrant portfolio should be reading the anti-dilution language at least as carefully as the strike.

What we watch as research analysts

Three patterns worth tracking over the next two quarters:

1. Volume of 6-Ks and 8-Ks disclosing pre-funded warrant exercises near beneficial-ownership caps. A cluster of forced exercises after a thin-volume month is a leading indicator of either an upcoming financing or a coordinated unwind.
2. Comment letters on the SEC's registered-offering reform. The warrant ecosystem's lobbying response to the unlisted-security carve-out will determine whether the next round of amendments closes the blue sky gap.
3. Accelerator warrant pools that originated from defunct programs. Where bankruptcy estates or surviving sponsors hold large warrant inventories with anti-dilution language, the structural mechanics described above govern what those positions are actually worth when issuers raise at depressed valuations.

None of this is investment advice and none of it is solicitation. It is the working framework we use in our own research, and the kind of structural detail we cover in the Equity Warrants & Accelerator Enforcement vertical of our weekly research. If you want to follow along, the daily insights page is the right place to start — and the weekly long-form sits on Substack.

Educational takeaway: warrants are not a single instrument. The combination of pre-funded structure, beneficial-ownership blocker, Section 4(a)(2) issuance, and anti-dilution language defines the real economics. Read all four together or you are reading the position incorrectly.

This is the part of the cycle where allocators get separated from speculators. Not because the Barclays number is wrong — it might be conservative — but because the path from $2B to $200B does not run through the company on the demo reel. It runs through a far less photogenic place: a warehouse outside Memphis where an autonomous mobile robot is moving a pallet right now. The deployment data published last week says so explicitly, and almost nobody on financial media bothered to read it.

The two phases Barclays actually described

Buried under the $200B headline was the part of Todorova’s framing that matters for capital allocation. Barclays calls this cycle "automation 3.0," and they split it into two phases that almost no retail commentary picked up. Through 2030: manufacturing, logistics, agriculture, construction. Industrial floors. Loading docks. Greenhouses. Job sites. Boring, dirty, measurable. After 2030: healthcare, elder care, education, hospitality. The consumer-facing humanoids. The ones retail is being sold today.

Read those two phases like an operator. The first phase is a buyer’s market — the customer has a CFO, a CapEx committee, a per-pallet cost spreadsheet, and a willingness to sign a five-year lease on a fleet that returns 18%. The second phase is a consumer adoption problem with regulatory risk, liability risk, and a hardware bill of materials that has to compete with human wages in the most labor-cost-sensitive industries in the economy. Phase one is shipping. Phase two is a pitch deck.

If you are buying the public humanoid story in 2026, you are buying phase two. The companies in phase one already have customers, contracts, and revenue. Most of them are private, late-stage, or buried inside industrials.

The deployment data nobody is quoting

ABI Research published a survey on June 4 covering 490 supply chain operators. The headline numbers are blunt enough to print on a t-shirt. 77% of supply chains are considering, piloting, or beginning implementation of mobile automation. 65% say AI and generative AI capability is important or very important to their next technology purchase decision. 55% plan to spend more than $100,000 on machine vision in the next two years. ABI’s qualitative read from MODEX 2026 was even sharper: the industry has moved from "experimentation to active deployment" and operators are now demanding "clear operational value — not vague promises."

Translate that out of survey-ese. The buyers stopped being curious and started being procurement. They want references. They want unit economics. They want a vendor that can quote a 36-month payback with a maintenance SLA. The hype cycle for "robots will do everything" is over inside the customer base. What replaced it is a buying cycle for things that already work.

The market that is shipping into that buying cycle is the logistics robot market. Fact.MR’s latest sizing puts it at $14.4 billion in 2025, $16.1 billion in 2026, and a projected $48.2 billion by 2036 — an 11.6% CAGR with autonomous mobile robots taking 29.4% of the product mix and warehouse automation at 33.7% of the application mix. That is not an AI fantasy curve. That is a CapEx procurement curve. And it is happening this fiscal year, not in 2035.

The Fear and Greed inversion

Here is the part allocators need to internalize. The Fear and Greed dial inside robotics is not pointed at the same companies the public market thinks it is. Retail greed is highest where the demo videos are loudest — humanoid bipeds folding shirts, sorting parts, walking up stairs. Operator greed is highest where the procurement cycle is closing — pallet movers, autonomous forklifts, vision-guided pickers, sortation systems with AI dispatch. The first crowd is bidding on a 2031 narrative. The second crowd is bidding on a 2026 invoice.

When the retail dial spikes greed, the operator dial spikes inventory. That is not a coincidence. That is how every previous automation cycle has cleared. Industrial robotics in the 1980s, semiconductor capex in the 1990s, cloud infrastructure in the 2010s — in every case, the headline trade got hyped two years after the boring middle of the supply chain had already locked in the volume. The investors who outperformed bought the boring middle. The investors who underperformed bought the avatar.

What we are watching at AdValorem

This is exactly the kind of split where edge actually lives, and it is the reason our AI and Robotics research vertical does not start with humanoid pure-plays. It starts with the question every allocator should be asking right now: which companies inside the phase-one buyer’s market are still private, still pre-IPO, and still allocating cap-table room to non-institutional capital? The answer is not zero. The answer is also not retail-accessible through a public ticker. It sits in the late-stage secondaries market, in accelerator alumni who shipped real industrial product before the 2024 robotics money got loud, and in a small set of warrant positions on companies that did the unglamorous integration work before the demo reels existed.

None of that is a deal. It is a research thesis. The point is not to predict the winner — the point is to be reading the deployment data while everyone else is watching the demo. Position before you predict. The Barclays $200B headline will still be there in five years. The procurement window for the boring middle is open right now.